Phoenix Biotech Aquisition Stock Quote PBAX - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

5.85

Bid

5.00

Ask

5.85

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

36.539M

Previous Close

5.85

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

6,246,000

Dividend Yield

PE Ratio

-14.41

Earnings Per Share (EPS)

-0.41

Revenue

Net Profit

-2.54M

Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportuni... Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportunity in any business, industry, sector or geographical location, industries that complement management team's background, and to capitalize on the ability of management team to identify and acquire a business in the healthcare or healthcare related industries in the United States and Europe. Show more

Sector

Blank Checks

Industry

Blank Checks

Website

www.cero.bio/

Headquarters

Wilmington, Delaware, USA

Founded

Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business Combination

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) (“PBAX”) and CERo Therapeutics, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics...

CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics

CERo is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Its lead product candidate is expected to...

Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021

Oakland, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the “Company”), a blank-check company formed for the purpose of acquiring or merging with one or...

Phoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option

Oakland, CA, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the “Company”), a blank-check company formed for the purpose of effecting a merger, share...

Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public Offering

Oakland, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the “Company”), a blank check company formed for the purpose of effecting a merger, share...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

PBAX - Frequently Asked Questions (FAQ)

What is the current Phoenix Biotech Aquisition share price?

The current share price of Phoenix Biotech Aquisition is $ 5.85

How many Phoenix Biotech Aquisition shares are in issue?

Phoenix Biotech Aquisition has 6,246,000 shares in issue

What is the market cap of Phoenix Biotech Aquisition?

The market capitalisation of Phoenix Biotech Aquisition is USD 36.54M

What is the 1 year trading range for Phoenix Biotech Aquisition share price?

Phoenix Biotech Aquisition has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Phoenix Biotech Aquisition?

The price to earnings ratio of Phoenix Biotech Aquisition is -14.41

What is the reporting currency for Phoenix Biotech Aquisition?

Phoenix Biotech Aquisition reports financial results in USD

What is the latest annual profit for Phoenix Biotech Aquisition?

The latest annual profit of Phoenix Biotech Aquisition is USD -2.54M

What is the registered address of Phoenix Biotech Aquisition?

The registered address for Phoenix Biotech Aquisition is RODNEY SQUARE, 1000 NORTH KING STREET, WILMINGTON, DELAWARE, 19801

What is the Phoenix Biotech Aquisition website address?

The website address for Phoenix Biotech Aquisition is www.cero.bio/

Which industry sector does Phoenix Biotech Aquisition operate in?

Phoenix Biotech Aquisition operates in the BLANK CHECKS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	$ 80.55 (8.54%)	281.23M